PHI-501, a novel and potent pan-RAF inhibitor in metastatic melanoma

被引：0
|
作者：
Kim, Namkyeong
Park, Jung Hee
Nam, Ky-Youb
Han, June H-J
Kim, Kyu-Tae
Sengupta, Sandip
Yoon, Jeong Hyeok
Sim, Taebo
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1627
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1627
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PHI-501, a novel pan-RAF/DDRs dual kinase inhibitor, overcomes BRAF or MEK inhibitor resistance in melanoma
    Kim, Sue Min
    Park, Jung Hee
    Nam, Ky-Youb
    Han, June H-J
    Kim, Kyu-Tae
    Yoon, Jeong Hyeok
    Sengupta, Sandip
    Sim, Taebo
    Shin, Sang Joon
    CANCER RESEARCH, 2023, 83 (07)
  • [2] PHI-501 is a novel potent next-generation pan-RAF/DDRs inhibitor, and overcomes resistance to RAF or MEK inhibitor in melanoma via dual inhibition of RAF and DDR1/2 signaling
    Kim, Sue Min
    Cho, Sungmin
    Sung, Gi-Jun
    Nam, Ky-Youb
    Han, June
    Shin, Sang Joon
    CANCER RESEARCH, 2024, 84 (06)
  • [3] PHI-501, a potent and novel inhibitor of NRAS mutated acute myeloid leukemia.
    Nam, Ky-Youb
    Park, Jung Hee
    Kim, Kyung Ah
    Shin, Inje
    Han, June H-J
    Kim, Kyu-Tae
    Yoon, Jeong Hyeok
    Cho, Hanna
    Choi, Seung-Hye
    Sengupta, Sandip
    Sim, Taebo
    CANCER RESEARCH, 2022, 82 (12)
  • [4] Discovery of a Highly Specific and Potent Pan-RAF Inhibitor
    Hong, Sung Pyo
    Lee, Younho
    Choi, Nam Song
    Nam, Ky-Youb
    Ahn, Soon Kil
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2016, 37 (10): : 1632 - 1637
  • [5] BIIB024, a potent pan-Raf kinase inhibitor for melanoma and solid tumors
    Elenbaas, B.
    Singh, L.
    Boccia, A.
    Cullen, P.
    Peng, H.
    Rohde, E.
    Raimundo, B.
    Kumaravel, G.
    Joseph, I.
    EJC SUPPLEMENTS, 2010, 8 (07): : 40 - 41
  • [6] Discovery of a highly potent pan-RAF inhibitor IHMT-RAF-128 for cancer treatment
    Wang, Aoli
    Liu, Juan
    Li, Xixiang
    Zou, Fengming
    Qi, Ziping
    Qi, Shuang
    Liu, Qingwang
    Wang, Zuowei
    Cao, Jiangyan
    Jiang, Zongru
    Wang, Beilei
    Ge, Juan
    Wang, Li
    Wang, Wenchao
    Liu, Jing
    Liu, Qingsong
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 952
  • [7] Preclinical characterization of QLH11906, a novel pan-RAF inhibitor
    Cheng, Zhe
    Chen, Fei
    Liu, Xile
    Gao, Cong
    Jia, Linchao
    Lao, Yuanzhi
    CANCER RESEARCH, 2022, 82 (12)
  • [8] Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
    Atefi, Mohammad
    Titz, Bjoern
    Avramis, Earl
    Ng, Charles
    Wong, Deborah J. L.
    Lassen, Amanda
    Cerniglia, Michael
    Escuin-Ordinas, Helena
    Foulad, David
    Comin-Anduix, Begonya
    Graeber, Thomas G.
    Ribas, Antoni
    MOLECULAR CANCER, 2015, 14
  • [9] Antitumor Activity of the Selective Pan-RAF Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma
    Nakamura, Akito
    Arita, Takeo
    Tsuchiya, Shuntarou
    Donelan, Jill
    Chouitar, Jouhara
    Carideo, Elizabeth
    Galvin, Katherine
    Okaniwa, Masanori
    Ishikawa, Tomoyasu
    Yoshida, Sei
    CANCER RESEARCH, 2013, 73 (23) : 7043 - 7055
  • [10] Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
    Mohammad Atefi
    Bjoern Titz
    Earl Avramis
    Charles Ng
    Deborah JL Wong
    Amanda Lassen
    Michael Cerniglia
    Helena Escuin-Ordinas
    David Foulad
    Begonya Comin-Anduix
    Thomas G Graeber
    Antoni Ribas
    Molecular Cancer, 14
12345